On February 17, 2026, director David W.J. McGirr informed Insmed ’s board that he will not stand for re-election at the 2026 annual meeting, though he will remain on the board and continue chairing ...
Stocktwits on MSN
Insmed’s new lung disease study data a win for company, says analyst
Truist has a ‘Buy’ rating on the shares with a price target of $205, representing a potential upside of about 51% from Friday’s closing price. ・Truist’s current base assumption is that Arikayce sales ...
Nontuberculous Mycobacteria (NTM), especially Mycobacterium avium-intracellulare complex (MAC), has been considered responsible for human disease, especially in HIV patients. Nevertheless, it has been ...
STUBBORN lung infection can evolve within patients and develop traits that help it persist over time. Chronic pulmonary disease caused by Mycobacterium avium complex remains difficult to manage and ...
A new study from researchers at the Trinity Translational Medicine Institute (TTMI) and the Irish Mycobacterial Reference Laboratory at St James’s Hospital has revealed how a hard-to-treat lung ...
Researchers Véronique Dartois, Ph.D., and Thomas Dick, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation in Nutley, N.J. The pair work with laboratory samples in developing their ...
Background: Mycobacterium avium (M. avium) is a nontuberculous mycobacterium (NTM) that can cause pulmonary and extrapulmonary infections mostly in immunocompromised individuals, such as those with ...
The present study is a report on the presence of Mycobacterium avium in four birds of the psittaciform order kept as pets. Anatomopathological diagnosis showed lesions suggestive of the agent and ...
Avian tuberculosis, also known as mycobacterium avium complex (MAC) or MAC lung disease, is a respiratory illness. It can lead to symptoms such as chronic cough, shortness of breath, and weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results